These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27664101)

  • 21. Treating the thyroid in the presence of Graves' ophthalmopathy.
    Hegedüs L; Bonnema SJ; Smith TJ; Brix TH
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):313-24. PubMed ID: 22632368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Graves' ophthalmopathy from the internist's perspective].
    Laubner K; Weber WA; Seufert J
    Ophthalmologe; 2011 May; 108(5):410-6. PubMed ID: 21590351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating Graves' orbitopathy.
    Dolman PJ
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):229-48. PubMed ID: 22632361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving treatment outcomes for Graves' disease patients with inactive forms of Graves' orbitopathy through an increased dose of radioiodine therapy.
    Gosmann J; Willms D; Bell E; Schreckenberger M; Willms A
    Nuklearmedizin; 2020 Jun; 59(3):260-268. PubMed ID: 32403138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life and neuropsychiatric disorders in patients with Graves' Orbitopathy: Current concepts.
    Bruscolini A; Sacchetti M; La Cava M; Nebbioso M; Iannitelli A; Quartini A; Lambiase A; Ralli M; de Virgilio A; Greco A
    Autoimmun Rev; 2018 Jul; 17(7):639-643. PubMed ID: 29729448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
    Bartalena L
    J Clin Endocrinol Metab; 2011 Mar; 96(3):592-9. PubMed ID: 21190983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raising awareness of Graves' orbitopathy with early warning cards.
    Mitchell AL; Hickey J; Vaidya B; Mason R; Ajjan R; Zammitt N; Perros P; Dayan C;
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):853-859. PubMed ID: 28755510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
    Genere N; Stan MN
    Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer aided volumetric assessment of orbital structures in patients with Graves' orbitopathy: correlation with serum thyroid antiperoxidase antibodies and disease activity.
    Paniagua L; Bande MF; Abalo-Lojo JM; Gonzalez F
    Int Ophthalmol; 2023 Sep; 43(9):3377-3384. PubMed ID: 37338774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.
    Abeillon-du Payrat J; Grunenwald S; Gall E; Ladsous M; Raingeard I; Caron P
    J Endocrinol Invest; 2023 Mar; 46(3):617-627. PubMed ID: 36378488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment options for Graves' orbitopathy.
    Marcocci C; Altea MA; Leo M
    Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.
    Leo M; Maggi F; Dottore GR; Casini G; Mazzetti P; Pistello M; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2017 May; 40(5):499-503. PubMed ID: 27987077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye.
    Sabini E; Ionni I; Rocchi R; Vitti P; Marcocci C; Marinò M
    Eur Thyroid J; 2018 Jan; 7(1):51-54. PubMed ID: 29594055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Graves' ophthalmopathy.
    Bartalena L
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):371-9. PubMed ID: 22632372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.
    Pawlowski P; Poplawska I; Mysliwiec J; Dik WA; Eckstein A; Berchner-Pfannschmidt U; Milewski R; Lawicki S; Dzieciol-Anikiej Z; Rejdak R; Reszec J
    Folia Histochem Cytobiol; 2020; 58(1):37-45. PubMed ID: 32176314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Features of Graves' Ophthalmopathy and Impact of Enalapril on the Course of Mild Graves' Ophthalmopathy: A Pilot Study.
    Ataabadi G; Dabbaghmanesh MH; Owji N; Bakhshayeshkaram M; Montazeri-Najafabady N
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):139-148. PubMed ID: 31345156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The thyroid, the eyes and the gut: a possible connection.
    Covelli D; Ludgate M
    J Endocrinol Invest; 2017 Jun; 40(6):567-576. PubMed ID: 28063079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
    Elbers L; Mourits M; Wiersinga W
    Thyroid; 2011 Mar; 21(3):279-83. PubMed ID: 21190446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric aspects in Graves' orbitopathy.
    Gogakos AI; Boboridis K; Krassas GE
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the pharmacological treatment of Graves' orbitopathy.
    Ruchała M; Sawicka-Gutaj N
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):981-9. PubMed ID: 26966785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.